B rown tumors are locally destructive bone lesions caused by rapid osteoclastic bone resorption due to severe hyperparathyroidism1. For years, brown tumors have been considered to be characteristic of primary hyperparathyroidism. However, brown tumors also have been reported to occur in patients with severe hyperparathyroidism secondary to chronic renal failure2-4, especially those on long-term hemo-dialysis. Hypocalcemia, hyperphosphatemia, and vitamin-D deficiency are the basic characteristics of chronic renal failure associated with secondary hyperparathyroidism. Fig. 1 Photograph of the lesion at presentation. The appearance of brown tumor lesions in a patient with secondary hyperparathyroidism due to malabsorption has been reported5; but, to our knowledge, there are no reported cases of a patient in whom brown tumor developed secondary to osteomalacia due to inadequate sunlight exposure and dietary vitamin-D deficiency. Our patient was informed that data concerning the case would be submitted for publication. A twenty-eight-year-old woman who had been in purdah (no skin exposed in public except the hands and face) since she was thirteen years old presented with a 4 × 3-cm painful mass in the region of the fourth metacarpal of the right hand without redness or warmth (Fig. 1). Her hand movement was extremely restricted. Radiographs revealed an expansile lytic lesion …
Objective. In this study we aimed to investigate causes of hyperparathyroidism and related factors in postmenopausal women. Methods. The study was conducted on 156 postmenopausal women, 43 with normal serum parathyroid hormone (PTH) levels and 113 with elevated serum PTH levels. Serum levels of 25-OH vitamin D, calcium and phosphorus, 24-hour urine calcium, phosphorus and calcium/creatinine ratio were compared between study groups. Also, bone mineral density, age of menopause, educational level, occupation, clothing style, daylight exposure time and daily dietary calcium consumption of subjects and relationships of these parameters with parathyroid hormone levels were investigated.Results. Causes of elevated serum PTH level were vitamin D deficiency in 92.9% and primary hyperparathyroidism in 4.4% of study group. Serum PTH levels were significantly higher in housewives (p<0.001), women with less than a high school graduates (p=0.008), and the veiled women (p=0.025). Serum 25-OH vitamin D levels were significantly lower in the veiled covered (p=0.002) and participants with less than a high school graduate (p=0.041). Significant negative correlation was detected between serum 25-OH vitamin D and the logarithmic value of serum PTH levels (r= -0.188; p=0.019). Conclusions. Vitamin D deficiency was common in all postmenopausal women but especially in those with lower education level and the veiled. Postmenopausal women should be screened for vitamin D deficiency and encouraged to benefit more from sunlight. Also, enriching foods in the markets with vitamin D may be helpful for decreasing hyperparathyroidism in this population.
Aims: Glomerular and tubulointerstitial damage plays a role in renal function failure in diabetic patients. While both serum and urine levels of neutrophil gelatinase-associated lipocalin (NGAL) show significantly increased levels in acute renal pathologies, the NGAL increase in active phase indicates a reversible condition in chronic cases. In this study, we determined if urinary excretion of NGAL can be used as an early indicator of diabetic nephropathy, which causes chronic renal damage. We compared urinary NGAL excretions both between type 1 diabetic patients and the healthy control group and between the patients with and without albuminuria within the type 1 diabetic group. The goal of this study was to investigate if NGAL excretion is sensitive enough for clinical use as an early indicator of nephropathy in diabetic patients. Methods: Fifty-two type 1 diabetic patients and 30 healthy volunteers participated in the study. The diabetic participants were separated into two groups as follows: a normoalbuminuria group consisting of those with an albumin/creatinine ratio less than 30 mg/g and an albuminuria group consisting of those with an albumin/creatinine ratio equal or greater than 30 mg/g. Albumin, creatinine and NGAL were measured in the morning spot urine samples of both the patient and the control group. Results: The median NGAL level of diabetes patients was 21.1 ng/ml, which was significantly higher than the corresponding value of 11.9 ng/ml in controls. When diabetic patients were compared as those with and without albuminuria, the median urinary NGAL levels of normoalbuminuria and albuminuria were 24.7 and 16.1 ng/ml, respectively, but the difference was not statistically significant. Conclusion: In type 1 diabetic patients, urinary NGAL excretion was increased but was not significantly correlated with urinary albumin excretion. The greater amount of NGAL excretion among diabetic patients may be due to diabetic nephropathy with possible tubulointerstitial damage pathologies. In this regard, urinary NGAL excretion should not be used as an alternative to microalbuminuria in detecting diabetic nephropathy. There is a need for further studies examining the long-term changes in NGAL excretion levels and renal functions.